COVID-19 vaccine landscape
dc.contributor.author | Seneviratne, S.L. | |
dc.contributor.author | Jayarajah, U. | |
dc.contributor.author | Abeysuriya, V. | |
dc.contributor.author | Rahman, A. | |
dc.contributor.author | Wanigasuriya, K. | |
dc.date.accessioned | 2021-01-04T14:18:22Z | |
dc.date.available | 2021-01-04T14:18:22Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 51(2):p.120-131 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/25210 | |
dc.publisher | Ceylon College of Physicians:Rajagiriya | |
dc.subject | COVID-19 | |
dc.subject | Vaccine | |
dc.subject | SARS-CoV-2 | |
dc.subject | Coronavirus | |
dc.subject | Coronavirus disease 2019 | |
dc.title | COVID-19 vaccine landscape | |
dc.type | Article |